Loading...
NMC Health Plc provides healthcare services in the United Arab Emirates, Spain, and internationally. The last earnings update was 185 days ago. More info.
7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
---|---|---|---|---|---|---|
NMC Health (NMC) | 1.2% | -0.8% | -22.8% | -20.6% | 209.8% | 512.7% |
GB Healthcare | 1.7% | -0.9% | -14.5% | -30.9% | -7.1% | 166.3% |
GB Market | 0.7% | 3.3% | 3.6% | -2.6% | 22.3% | -1.2% |
Is NMC Health undervalued based on future cash flows and its price relative to the stock market?
Below are the data sources, inputs and calculation used to determine the intrinsic value for NMC Health.
Data Point | Source | Value |
---|---|---|
Valuation Model | 2 Stage Free Cash Flow to Equity | |
Levered Free Cash Flow | Average of 9 Analyst Estimates (S&P Global) | See below |
Discount Rate (Cost of Equity) | See below | 8.2% |
Perpetual Growth Rate | 10-Year GB Government Bond Rate | 1.2% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
Data Point | Calculation/ Source | Result |
---|---|---|
Risk-Free Rate | 10-Year GB Govt Bond Rate | 1.2% |
Equity Risk Premium | S&P Global | 8.8% |
Healthcare Unlevered Beta | Simply Wall St/ S&P Global | 0.31 |
Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.305 (1 + (1- 19%) (25.93%)) |
0.37 |
Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
0.8 |
Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.23% + (0.8 * 8.77%) |
8.25% |
Discounted Cash Flow Calculation for LSE:NMC using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for NMC Health is arrived at by discounting future cash flows to their present value using the 2 stage method. We use analyst's estimates of cash flows going forward 5 years for the 1st stage, the 2nd stage assumes the company grows at a stable rate into perpetuity.
2019 | 2020 | 2021 | 2022 | 2023 | |
Levered FCF (USD, Millions) | 245.40 | 400.47 | 443.20 | 531.40 | 616.42 |
Source | Analyst x5 | Analyst x5 | Analyst x2 | Analyst x1 | Est @ 16%, capped from 26.52% |
Present Value Discounted (@ 8.25%) |
226.71 | 341.78 | 349.44 | 387.06 | 414.79 |
Present value of next 5 years cash flows | $1,719.79 |
Calculation | Result | |
---|---|---|
Terminal Value |
= FCF2023
× (1 + g) ÷ (Discount Rate – g)
= $616.42 × (1 + 1.23%) ÷ (8.25% – 1.23%) |
$8,890.74 |
Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)5
= $8,890.74 ÷ (1 + 8.25%)5 |
$5,982.61 |
Calculation | Result | |
---|---|---|
Total Equity Value |
= Present value of next 5 years cash flows +
Terminal Value
= $1,719.79 + $5,982.61 |
$7,702.40 |
Equity Value per Share (USD) |
= Total value / Shares Outstanding
= $7,702.40 / 208.40 |
$36.96 |
Calculation | Result | |
---|---|---|
Exchange Rate | USD/GBP
(Reporting currency to currency of LSE:NMC) |
0.766 |
Value per Share (GBP) |
= Value per Share in USD x Exchange Rate (USD/GBP)
= $36.96 x 0.766 |
£28.32 |
Value per share (GBP) | From above. | £28.32 |
Current discount | Discount to share price of
£27.88
= -1 x (£27.88 - £28.32) / £28.32 |
1.6% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
Data Point | Source | Value |
---|---|---|
Earnings Per Share * | Company Filings (2018-06-30) in USD | $1.04 |
LSE:NMC Share Price ** | LSE (2019-02-21) in GBP | £27.88 |
LSE:NMC Share Price converted to USD reporting currency | Exchange rate (GBP/ USD) 1.305 | $36.38 |
United Kingdom of Great Britain and Northern Ireland Healthcare Industry PE Ratio | Median Figure of 11 Publicly-Listed Healthcare Companies | 25.04x |
United Kingdom of Great Britain and Northern Ireland Market PE Ratio | Median Figure of 815 Publicly-Listed Companies | 16.24x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of NMC Health.
Calculation | Outcome | |
---|---|---|
PE Ratio | = LSE:NMC Share Price ÷ EPS (both in USD) = 36.38 ÷ 1.04 |
34.89x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
Data Point | Source | Value |
---|---|---|
PE Ratio | See PE Ratio Section | 34.89x |
Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 9 Analysts |
19.7%per year |
United Kingdom of Great Britain and Northern Ireland Healthcare Industry PEG Ratio | Median Figure of 9 Publicly-Listed Healthcare Companies | 1.68x |
United Kingdom of Great Britain and Northern Ireland Market PEG Ratio | Median Figure of 570 Publicly-Listed Companies | 1.31x |
*Line of best fit is calculated by linear regression .
Calculation | Outcome | |
---|---|---|
PEG Ratio | = PE Ratio ÷ Net Income Annual Growth Rate = 34.89x ÷ 19.7% |
1.77x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
Data Point | Source | Value |
---|---|---|
Book Value per Share | Company Filings (2018-06-30) in USD | $5.63 |
LSE:NMC Share Price * | LSE (2019-02-21) in GBP | £27.88 |
LSE:NMC Share Price converted to USD reporting currency | Exchange rate (GBP/ USD) 1.305 | $36.38 |
United Kingdom of Great Britain and Northern Ireland Healthcare Industry PB Ratio | Median Figure of 15 Publicly-Listed Healthcare Companies | 1.25x |
United Kingdom of Great Britain and Northern Ireland Market PB Ratio | Median Figure of 1,361 Publicly-Listed Companies | 1.53x |
Calculation | Outcome | |
---|---|---|
PB Ratio | = LSE:NMC Share Price ÷ Book Value per Share (both in USD) = 36.38 ÷ 5.63 |
6.46x |
* Primary Listing of NMC Health.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
How is NMC Health expected to perform in the next 1 to 3 years based on estimates from 9 analysts?
Data Point | Source | Value (per year) |
---|---|---|
LSE:NMC Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 9 Analysts | 19.7% |
LSE:NMC Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 9 Analysts | 13.6% |
United Kingdom of Great Britain and Northern Ireland Healthcare Industry Earnings Growth Rate | Market Cap Weighted Average | 26.6% |
United Kingdom of Great Britain and Northern Ireland Healthcare Industry Revenue Growth Rate | Market Cap Weighted Average | 10.5% |
United Kingdom of Great Britain and Northern Ireland Market Earnings Growth Rate | Market Cap Weighted Average | 9.9% |
United Kingdom of Great Britain and Northern Ireland Market Revenue Growth Rate | Market Cap Weighted Average | 3.7% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Data Point | Source | Value |
---|---|---|
Past Financials | Company Filings (7 months ago) | See Below |
Future Estimates | Average of up to 9 Analyst Estimates (S&P Global) | See Below |
Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
---|---|---|---|---|
2023-12-31 | ||||
2022-12-31 | 3,277 | 701 | 600 | 2 |
2021-12-31 | 3,030 | 568 | 504 | 3 |
2020-12-31 | 2,866 | 542 | 441 | 8 |
2019-12-31 | 2,478 | 383 | 364 | 9 |
2018-12-31 | 1,996 | 318 | 285 | 9 |
Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * |
---|---|---|---|
2018-06-30 | 1,760 | 262 | 215 |
2018-03-31 | 1,682 | 270 | 200 |
2017-12-31 | 1,603 | 278 | 186 |
2017-09-30 | 1,511 | 234 | 172 |
2017-06-30 | 1,418 | 191 | 158 |
2017-03-31 | 1,319 | 184 | 145 |
2016-12-31 | 1,221 | 176 | 133 |
2016-09-30 | 1,143 | 155 | 119 |
2016-06-30 | 1,065 | 134 | 105 |
2016-03-31 | 973 | 109 | 94 |
2015-12-31 | 881 | 84 | 82 |
2015-09-30 | 802 | 79 | 79 |
*GAAP earnings excluding extraordinary items.
Data Point | Source | Value |
---|---|---|
Past Financials | Company Filings (7 months ago) | See Below |
Future Estimates | Average of up to 9 Analyst Estimates (S&P Global) | See Below |
All data from NMC Health Company Filings, last reported 7 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
Date (Data in USD Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
---|---|---|---|---|
2023-12-31 | ||||
2022-12-31 | 3.35 | 3.35 | 3.35 | 1.00 |
2021-12-31 | 2.43 | 2.82 | 2.00 | 3.00 |
2020-12-31 | 2.08 | 2.24 | 1.87 | 5.00 |
2019-12-31 | 1.72 | 1.80 | 1.61 | 6.00 |
2018-12-31 | 1.36 | 1.42 | 1.27 | 6.00 |
Date (Data in USD Millions) | EPS * |
---|---|
2018-06-30 | 1.04 |
2018-03-31 | 0.98 |
2017-12-31 | 0.91 |
2017-09-30 | 0.86 |
2017-06-30 | 0.81 |
2017-03-31 | 0.76 |
2016-12-31 | 0.71 |
2016-09-30 | 0.64 |
2016-06-30 | 0.57 |
2016-03-31 | 0.50 |
2015-12-31 | 0.44 |
2015-09-30 | 0.43 |
*GAAP earnings excluding extraordinary items.
How has NMC Health performed over the past 5 years?
All data from NMC Health Company Filings, last reported 7 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
Date (Data in USD Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
---|---|---|---|---|
2018-06-30 | 1,760.21 | 214.74 | 366.32 | |
2018-03-31 | 1,681.80 | 200.35 | 350.75 | |
2017-12-31 | 1,603.40 | 185.97 | 335.17 | |
2017-09-30 | 1,510.52 | 172.01 | 318.54 | |
2017-06-30 | 1,417.65 | 158.04 | 301.92 | |
2017-03-31 | 1,319.24 | 145.37 | 284.91 | |
2016-12-31 | 1,220.84 | 132.69 | 267.90 | |
2016-09-30 | 1,143.15 | 118.82 | 249.79 | |
2016-06-30 | 1,065.46 | 104.96 | 231.68 | |
2016-03-31 | 973.16 | 93.59 | 211.46 | |
2015-12-31 | 880.87 | 82.22 | 191.25 | |
2015-09-30 | 802.12 | 79.04 | 174.54 | |
2015-06-30 | 723.37 | 75.87 | 157.83 | |
2015-03-31 | 683.65 | 76.22 | 147.51 | |
2014-12-31 | 643.93 | 76.57 | 137.19 | |
2014-09-30 | 618.02 | 76.63 | 132.62 | |
2014-06-30 | 592.10 | 76.70 | 128.06 | |
2014-03-31 | 571.49 | 72.43 | 123.81 | |
2013-12-31 | 550.88 | 68.17 | 119.56 | |
2013-09-30 | 538.02 | 65.89 | 115.49 | |
2013-06-30 | 525.17 | 63.61 | 111.42 | |
2013-03-31 | 507.61 | 61.25 | 108.24 | |
2012-12-31 | 490.05 | 58.89 | 105.06 | |
2012-09-30 | 476.14 | 53.25 | 98.46 | |
2012-06-30 | 462.22 | 47.61 | 91.87 | |
2012-03-31 | 452.99 | 45.30 | 85.36 |
*GAAP earnings excluding extraordinary items.
How is NMC Health's financial health and their level of debt?
All data from NMC Health Company Filings, last reported 7 months ago.
Date (Data in USD Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
---|---|---|---|
2018-06-30 | 1,211.55 | 1,966.21 | 432.62 |
2018-03-31 | 1,211.55 | 1,966.21 | 432.62 |
2017-12-31 | 1,144.63 | 1,399.03 | 387.61 |
2017-09-30 | 1,144.63 | 1,399.03 | 387.61 |
2017-06-30 | 1,027.20 | 1,344.77 | 294.94 |
2017-03-31 | 1,027.20 | 1,344.77 | 294.94 |
2016-12-31 | 948.87 | 1,049.15 | 617.84 |
2016-09-30 | 948.87 | 1,049.15 | 617.84 |
2016-06-30 | 569.37 | 994.97 | 204.77 |
2016-03-31 | 569.37 | 994.97 | 204.77 |
2015-12-31 | 499.67 | 730.31 | 177.40 |
2015-09-30 | 499.67 | 730.31 | 177.40 |
2015-06-30 | 451.99 | 663.90 | 254.57 |
2015-03-31 | 451.99 | 663.90 | 254.57 |
2014-12-31 | 453.03 | 376.12 | 263.17 |
2014-09-30 | 453.03 | 376.12 | 263.17 |
2014-06-30 | 416.17 | 327.09 | 227.48 |
2014-03-31 | 416.17 | 327.09 | 227.48 |
2013-12-31 | 389.15 | 332.44 | 268.70 |
2013-09-30 | 389.15 | 332.44 | 268.70 |
2013-06-30 | 352.29 | 302.58 | 248.61 |
2013-03-31 | 352.29 | 302.58 | 248.61 |
2012-12-31 | 331.60 | 303.64 | 257.45 |
2012-09-30 | 331.60 | 303.64 | 257.45 |
2012-06-30 | 299.35 | 251.80 | 276.58 |
2012-03-31 | 299.35 | 251.80 | 276.58 |
What is NMC Health's current dividend yield, its reliability and sustainability?
Data Point | Source | Value |
---|---|---|
Past Annualized Dividend Yield | S&P Global Market Data | See Below |
Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
Future Dividends per Share Estimates | Average of up to 9 Analyst Estimates (S&P Global) | See Below |
United Kingdom of Great Britain and Northern Ireland Healthcare Industry Average Dividend Yield | Market Cap Weighted Average of 11 Stocks | 1.5% |
United Kingdom of Great Britain and Northern Ireland Market Average Dividend Yield | Market Cap Weighted Average of 709 Stocks | 4.2% |
United Kingdom of Great Britain and Northern Ireland Minimum Threshold Dividend Yield | 10th Percentile | 1.1% |
United Kingdom of Great Britain and Northern Ireland Bottom 25% Dividend Yield | 25th Percentile | 1.9% |
United Kingdom of Great Britain and Northern Ireland Top 25% Dividend Yield | 75th Percentile | 5.2% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
Date (Data in $) | Dividend per Share (annual) | Avg. No. Analysts |
---|---|---|
2023-12-31 | ||
2022-12-31 | 0.62 | 1.00 |
2021-12-31 | 0.46 | 4.00 |
2020-12-31 | 0.41 | 9.00 |
2019-12-31 | 0.33 | 10.00 |
2018-12-31 | 0.26 | 10.00 |
Date (Data in $) | Dividend per share (annual) | Avg. Yield (%) |
---|---|---|
2018-05-25 | 0.163 | 0.395 |
2017-04-24 | 0.134 | 0.386 |
2016-04-29 | 0.075 | 0.449 |
2016-03-14 | 0.087 | 0.578 |
2015-05-20 | 0.075 | 0.660 |
2014-02-25 | 0.064 | 0.864 |
2013-02-26 | 0.061 | 1.202 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
Mr. Prasanth Manghat has been the Chief Executive Officer of NMC Health Plc since March 8, 2017. Mr. Manghat served as Deputy Chief Executive Officer of NMC Health Plc since January 1, 2015 until March 8, 2017. Mr. Manghat served as the Chief Financial Officer of NMC Health Plc since 2011 until December 31, 2014. Mr. Manghat has 20 years’ experience in accounting, corporate finance, treasury and banking, including 14 years’ in NMC related businesses and financial reporting activities. He has been a part of the NMC Health Group for 11 years and spearheaded NMC Healthcare’s successful listing on the Premium Segment of the London Stock Exchange in April 2012, the first UAE-based company so to do, raising US$ 187 million. He worked as Credit & Operations Head with Kotak Mahindra Finance, one of the leading non-banking financial institutions in India. Mr. Manghat has been an Executive Director of NMC Health Plc since June 26, 2014. He has been acknowledged and recognised at many business and social forums. He is a Chartered Accountant. Mr. Manghat is a Fellow member of the Institute of Chartered Accountants of India (FCA) and a member of the Association of Chartered Certified Accountants in the UK. He is a Bachelor of Science from MG University, Kerala, India in 1995. He was honored with the “CFO of the Year” award in 2012 by ICAEW, Middle-East. He was also conferred with the prestigious award for “Excellence in Finance” by the Institute of Chartered Accountants of India, Abu Dhabi Chapter in November, 2012 and “Professional Excellence Award in the Healthcare Sector” by ICAI UAE (Dubai) Chapter in May 2013.
Average tenure and age of the NMC Health management team in years:
Average tenure and age of the NMC Health board of directors in years:
Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price (£) | Value (£) | |
---|---|---|---|---|---|---|---|---|---|---|
27. Dec 18 | Buy | Salma Ali Saif Bin Hareb Almheiri | Individual | 24. Dec 18 | 24. Dec 18 | 5,500 | £26.99 | £148,449 | ||
20. Dec 18 | Buy | Michael Davis | Individual | 19. Dec 18 | 19. Dec 18 | 1,770 | £27.89 | £49,365 | ||
20. Dec 18 | Sell | Henry J. Tompkins | Individual | 19. Dec 18 | 19. Dec 18 | -1,770 | £27.89 | £-49,365 | ||
19. Dec 18 | Sell | Henry J. Tompkins | Individual | 17. Dec 18 | 17. Dec 18 | -2,500 | £29.20 | £-73,004 | ||
10. Dec 18 | Sell | Henry J. Tompkins | Individual | 06. Dec 18 | 06. Dec 18 | -550 | £31.08 | £-17,094 | ||
24. Oct 18 | Sell | Henry J. Tompkins | Individual | 22. Oct 18 | 22. Oct 18 | -800 | £32.18 | £-25,744 |
Your equity share is granted in return for the capital provided to the business to operate, and in order for an investment to be successful the business has to create earnings from the funds that make up this capital. … You need to pay attention to this because your return on investment is linked to dividends and internal investments to improve the business, which can only occur if the company is expected to produce adequate earnings with the capital that has been provided. … Therefore, looking at how efficiently NMC Health is able to use capital to create earnings will help us understand your potential return.
Simply Wall St - – Full articleAfter looking at NMC Health Plc's (LON:NMC) latest earnings announcement (31 December 2017), I found it useful to revisit the company's performance in the past couple of years and assess this against the most recent figures. … Did NMC's recent earnings growth beat the long-term trend and the industry. … NMC's trailing twelve-month earnings (from 31 December 2017) of US$185.97m has
Simply Wall St - – Full articleWhat is left after investment, determines the value of the stock since this cash flow technically belongs to investors of the company. … I will take you through NMC Health’s cash flow health and the risk-return concept based on the stock’s cash flow yield, using the most recent financial data. … NMC Health’s free cash flow (FCF) is the level of cash flow the business generates from its operational activities, after it reinvests in the company as capital expenditure.
Simply Wall St - – Full articleAs analysts forecast … NMC Health Plc (LON:NMC) to … earnings growth of 22.01% annualised
Simply Wall St - – Full articleSmall and large cap stocks are widely popular for a variety of reasons, however, mid-cap companies such as NMC Health Plc (LON:NMC), with a market cap of UK£7.37b, often get neglected by retail investors. … Today we will look at NMC’s financial liquidity and debt levels, which are strong indicators for whether the company can weather economic downturns or fund strategic acquisitions for future growth. … Remember this is a very top-level look that focuses exclusively on financial health, so I recommend a deeper analysis.
Simply Wall St - – Full articleThere's no stopping the NMC Health Plc (LON:NMC) growth train, with analysts forecasting high top-line growth in the near future. … I will touched on some key aspects you should know on a high level, around its financials and growth prospects going forward
Simply Wall St - – Full articleGrowth expectations for NMC Health Plc (LON:NMC) are high, but many investors are starting to ask whether its last close at £35.66 can still be rationalized by the future potential. … Let’s take a look at some key metrics to determine whether there's any value here for current and potential future investors. … What can we expect from NMC Health in the future.
Simply Wall St - – Full articleNMC Health Plc (LSE:NMC) is considered a high-growth stock, but its last closing price of £37.74 left some investors wondering if this high future earnings potential can be rationalized by its current price tag. … But, since NMC Health is a high-growth stock, we must also account for its earnings growth by using calculation called the PEG ratio. … A PE ratio of 55.36x and expected year-on-year earnings growth of 21.17% give NMC Health a quite high PEG ratio of 2.61x.
Simply Wall St - – Full articleAfter reading NMC Health Plc's (LSE:NMC) latest earnings update (31 December 2017), I found it beneficial to look back at how the company has performed in the past and compare this against the most recent numbers. … Check out our latest analysis for NMC Health How NMC fared against its long-term earnings performance and its industry For the most up-to-date info, I use data from the most recent 12 months, which annualizes the most recent half-year data, or in some cases, the latest annual report is already the most recent financial year data. … This means whatever recent headwind the industry is facing, the impact on NMC Health has been softer relative to its peers.What does this mean?
Simply Wall St - – Full articleThis means that if you believe the current share price should move towards its intrinsic value over time, a low beta could suggest it is not likely to reach that level anytime soon, and once it’s there, it may be hard to fall back down into an attractive buying range again. … Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. … NMC’s optimistic future growth appears to have been factored into the current share price, with shares trading above its fair value.
Simply Wall St - – Full article
NMC Health Plc provides healthcare services in the United Arab Emirates, Spain, and internationally. The company operates through two businesses, NMC Healthcare and NMC Trading. It owns and manages approximately 135 healthcare facilities that include hospitals, medical centers, long term care facilities, day surgery centers, fertility centers, and home health services providers. The company has developed specialized verticals covering multi-specialty care, maternity and fertility, long-term and home care, operations and management, and distribution services. It is also involved in the distribution of pharmaceutical products, medical equipment, medical consumables and devices, education and office supplies, veterinary products, cosmetics, IT products, and rehab supplies, as well as consumer products, including personal care, food and beverages, household care, and home improvement products. The company was founded in 1975 and is based in London, the United Kingdom.
Name: | NMC Health Plc |
NMC | |
Exchange: | LSE |
Founded: | 1975 |
£5,810,089,011 | |
208,396,306 | |
Website: | http://www.nmchealth.com |
Address: |
NMC Health Plc Devonshire House, Level 1, London, Greater London, W1J 8AJ, United Kingdom |
Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
---|---|---|---|---|---|---|---|
LSE | NMC | Ordinary Shares | London Stock Exchange | GB | GBP | 02. Apr 2012 | |
OTCPK | NMMC.F | Ordinary Shares | Pink Sheets LLC | US | USD | 02. Apr 2012 | |
BATS-CHIXE | NMCL | Ordinary Shares | BATS 'Chi-X Europe' | GB | GBP | 02. Apr 2012 | |
OTCPK | NMHL.Y | UNSPONSORED ADR | Pink Sheets LLC | US | USD | 08. Jul 2015 |
Health Care Facilities | |
Healthcare |
Area | Date (UTC time) |
---|---|
Company Analysis updated: | 2019/02/21 21:54 |
End of day share price update: | 2019/02/21 00:00 |
Last estimates confirmation: | 2019/02/21 |
Last earnings filing: | 2018/08/20 |
Last earnings reported: | 2018/06/30 |
Last annual earnings reported: | 2017/12/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.